A bipartisan group of members of the House Energy and Commerce Committee introduced new legislation to reform the FDA’s monograph system for over-the-counter ingredients and replace the agency’s rulemaking process for approving OTCs with a system based on administrative orders.
Source: Drug Industry Daily